8 results
·
18ms
·
Sources: EU EUDAMED, US FDA
GLUCOSE, HEXOKINASE (R1), MODEL GL101-01, GLUCOSE HEXOKINASE (R2), MODEL GL101-02
FDA 510(k)
FDA Class 2
·Clinical Chemistry
NEX-D2 Posterior Fixation System
FDA 510(k)
FDA Class 2
·Orthopedic
MODIFICATION TO: NUVASIVE SPHERX SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
PKG, WEIGHTED LIGHT HANDLE, VISUM LED
FDA Adverse Event
Malfunction
·STRYKER-COMMUNICATIONS·Product code FSY·March 6, 2013
CAPSUREFIX NOVUS
FDA Adverse Event
Injury
·MPRI·Product code DTB·August 8, 2014
530G INSULIN PUMP
FDA Adverse Event
Injury
·MEDTRONIC MINIMED·Product code OZO·August 11, 2015
TI END CAP W/T40 STRDRV 15MM EXT-STER F/TI TIBIAL NAILS-EX
FDA Adverse Event
Malfunction
·OBERDORF SYNTHES PRODUKTIONS GMBH·Product code JDS·October 17, 2018
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012